{"count": 1, "results": [{"_id": "33035320", "pmid": 33035320, "title": "Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women.", "journal": "J Clin Endocrinol Metab", "authors": ["Fischer NM", "Nieuwenhuis TO", "Singh B", "Yenokyan G", "Segars JH"], "date": "2021-01-23T00:00:00Z", "doi": "10.1210/clinem/dgaa718", "meta_date_publication": "2021 Jan 23", "meta_volume": "106", "meta_issue": "2", "meta_pages": "e650-e659", "score": 50254.21, "text_hl": "This association was significant for each age group: 30 to 39 years (OR 0.86; 95% CI, 0.74-0.99), 40 to 49 years (OR 0.71; 95% CI, 0.66-0.76), 50 to 59 years (OR 0.63; 95% CI, 0.58-0.69), and 60 to 65 years (OR 0.58; 95% CI, 0.50-0.69). Of the ACEis, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (OR 0.67; 95% CI, 0.64-0.71), @CHEMICAL_Quinapril @CHEMICAL_MESH:D000077583 @@@quinapril@@@ (OR 0.62; 95% CI, 0.41-0.92), and @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@ (OR 0.35; 95% CI, 0.23-0.50) demonstrated a significant association with reduced @<m>DISEASE_Leiomyoma</m> @DISEASE_MESH:D007889 @@@leiomyoma@@@ incidence. ", "citations": {"NLM": "Fischer NM, Nieuwenhuis TO, Singh B, Yenokyan G, Segars JH. Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e650-e659. PMID: 33035320", "BibTeX": "@article{33035320, title={Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women.}, author={Fischer NM and Nieuwenhuis TO and Singh B and Yenokyan G and Segars JH}, journal={J Clin Endocrinol Metab}, volume={106}, number={2}, pages={e650-e659}}"}}]}